001     912547
005     20230816204234.0
024 7 _ |a 10.1093/nop/npac059
|2 doi
024 7 _ |a 2054-2577
|2 ISSN
024 7 _ |a 2054-2585
|2 ISSN
024 7 _ |a 2128/33903
|2 Handle
024 7 _ |a 36388412
|2 pmid
024 7 _ |a WOS:000885427200002
|2 WOS
037 _ _ |a FZJ-2022-05720
082 _ _ |a 610
100 1 _ |a Galldiks, Norbert
|0 P:(DE-Juel1)143792
|b 0
|e Corresponding author
245 _ _ |a Imaging patterns in patients with newly diagnosed glioblastoma in England
260 _ _ |a Oxford
|c 2022
|b Oxford Univ. Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1692187424_26781
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The study by Dumba and colleagues1 explored the incidence and timing of various peridiagnostic neuroimaging techniques such as MRI, CT, and PET in patients with newly diagnosed glioblastoma using a national database. Particularly, preoperative, early postoperative, and pre-radiotherapy imaging patterns for all glioblastoma patients aged 15–99 years resident in England in the years 2013 and 2014 were retrospectively evaluated.The entire cohort for data analysis comprised 4,307 patients. The main finding of the study is that prediagnostic imaging appears uniform, whereas postdiagnostic imaging practice varied considerably. Of note, the authors observed that there is clear evidence for low use of early postoperative MRI, the low use of additional MR imaging before radiotherapy, and the very limited use of other neuroimaging techniques such as advanced MRI and PET. For example, in the group of patients who underwent surgery and chemoradiation, only 51% had an early postoperative MRI within 72 hours after surgery. In patients undergoing surgery who subsequently received radiotherapy, only 61% had both an early postoperative and a pre-radiotherapy MRI. To improve the diagnostic performance, only 7% of the cohort underwent one or more of the advanced MRI options (ie, perfusion-weighted MRI, proton MR spectroscopy), and less than 1% of the cohort had additional PET imaging with various tracers (eg, radiolabeled amino acids, [18F]-2-fluoro-2-deoxy-D-glucose) during the course of the disease.
536 _ _ |a 5252 - Brain Dysfunction and Plasticity (POF4-525)
|0 G:(DE-HGF)POF4-5252
|c POF4-525
|f POF IV
|x 0
588 _ _ |a Dataset connected to DataCite
700 1 _ |a Lohmann, Philipp
|0 P:(DE-Juel1)145110
|b 1
773 _ _ |a 10.1093/nop/npac059
|g Vol. 9, no. 6, p. 461 - 462
|0 PERI:(DE-600)2768945-1
|n 6
|p 461 - 462
|t Neuro-oncology practice
|v 9
|y 2022
|x 2054-2577
856 4 _ |u https://juser.fz-juelich.de/record/912547/files/Galldiks_2022_Imaging%20patterns%20in%20patients%20with%20newly%20diagnosed%20glioblastoma%20in%20England.pdf
|y Published on 2022-12-06. Available in OpenAccess from 2023-12-06.
909 C O |o oai:juser.fz-juelich.de:912547
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 0
|6 P:(DE-Juel1)143792
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 1
|6 P:(DE-Juel1)145110
913 1 _ |a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|1 G:(DE-HGF)POF4-520
|0 G:(DE-HGF)POF4-525
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-500
|4 G:(DE-HGF)POF
|v Decoding Brain Organization and Dysfunction
|9 G:(DE-HGF)POF4-5252
|x 0
914 1 _ |y 2022
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-15
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2022-11-15
915 _ _ |a Embargoed OpenAccess
|0 StatID:(DE-HGF)0530
|2 StatID
915 _ _ |a WoS
|0 StatID:(DE-HGF)0112
|2 StatID
|b Emerging Sources Citation Index
|d 2022-11-15
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-15
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2022-11-15
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-15
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2020-09-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-15
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-3-20090406
|k INM-3
|l Kognitive Neurowissenschaften
|x 0
920 1 _ |0 I:(DE-Juel1)INM-4-20090406
|k INM-4
|l Physik der Medizinischen Bildgebung
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)INM-3-20090406
980 _ _ |a I:(DE-Juel1)INM-4-20090406
980 _ _ |a UNRESTRICTED
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21